Cannara Biotech to Host Investor Webcast on Thursday December 19th, 2024
Cannara Biotech (TSXV: LOVE) (OTCQB: LOVFF) has announced an upcoming investor webcast scheduled for Thursday, December 19th, 2024, at 2:00 PM ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Cannara Biotech (TSXV: LOVE) (OTCQB: LOVFF) has announced an upcoming investor webcast scheduled for Thursday, December 19th, 2024, at 2:00 PM ET. The company, a vertically integrated cannabis producer operating two mega facilities in Quebec with over 1,650,000 sq. ft. of space, will feature CFO Nicholas Sosiak presenting key financial and operational results for the fiscal year ended August 31, 2024.
The presentation will be followed by an interactive Q&A session where investors can engage directly with management. Pre-registration is required through the provided Zoom webinar link, and an archived version of the webcast and presentation will be available on Cannara's investor relations website.
Details
News Market Reaction – LOVFF
The recorded move for LOVFF in the trading session of this news was -3.49%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MONTREAL, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (“Cannara”, “the Company”, “us” or “we”) (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade cannabis and derivative product offerings at affordable prices with two mega facilities based in Quebec spanning over 1,650,000 sq. ft., today announced that it will host a webcast investor presentation on Thursday, December 19th, 2024, at 2:00 PM ET.
During the webcast, Nicholas Sosiak, CFO, will conduct a presentation that will cover key financial and operational results for the fiscal year ended August 31, 2024. After the formal presentation, investors will have an opportunity to ask relevant questions through an interactive Q&A session.
Date & Time: December 19, 2024, at 2:00 PM ET
Webcast Link: https://us02web.zoom.us/webinar/register/WN_QVPjGIwzSvKgaiRBHLBfrQ
To listen to the webcast or participate in the live Q&A, please pre-register using the link provided above. An archived version of the webcast and presentation will be available on the Company's website, https://investors.cannara.ca/
ABOUT CANNARA
Cannara Biotech Inc. (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0), is a vertically integrated producer of affordable premium-grade cannabis and cannabis-derivative products for the Canadian markets. Cannara owns two mega facilities based in Québec spanning over 1,650,000 sq. ft., providing the Company with 100,000 kg of potential annualized cultivation output. Leveraging Québec’s low electricity costs, Cannara’s facilities produce premium-grade cannabis products at an affordable price. For more information, please visit cannara.ca.
CONTACT
| Nicholas Sosiak, CPA, CA Chief Financial Officer nick@cannara.ca | Zohar Krivorot President & Chief Executive Officer zohar@cannara.ca |
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.